Navamedic Q4 and Full Year 2024: Continued growth in a year with investments in new growth initiatives Oslo, 12 February 2025 – For the full year 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable…
Observe Medical ASA – Resignation of board member Oslo, 4 February 2025: Board member Kathrine Elisabeth Gamborg Andreassen has informed the board of directors of Observe Medical ASA…
Observe Medical ASA: New share capital registered Oslo, 17 December 2024 Reference is made to the announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker…
Observe Medical ASA: Notification of transaction by close associate to primary insider and disclosure of large shareholding Oslo, 5 December 2024: Reference is made to the stock announcement published by Observe Medical ASA (the "Observe Medical") on…
Observe Medical ASA: Final result of the subsequent offering and allocation of shares; Updated amendments of loans from Navamedic ASA to be implemented including partial conversion to shares NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN,…
Observe Medical ASA: Amendments to loan agreements with Navamedic ASA Oslo, 15 November 2024: Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on…
Navamedic ASA: Mandatory notice of trade Oslo, November 6, 2024: Lars Hjarrand, CFO and a primary insider of Navamedic ASA, has today bought 20.000 Navamedic ASA…
Navamedic launches Eroxon[®] in Finland Oslo, 6 November 2024 – Building on the successful product launch of Eroxon[®] in Norway and Sweden earlier this year,…
NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS Oslo, 9 September 2024: The board of directors of Navamedic ASA (the "Company"), has today, on 9 September 2024, in…
Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement Oslo, 16 August 2024 – In first half of 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable…
Navamedic ASA: Notice of Annual General Meeting The annual general meeting of Navamedic ASA (OSE: NAVA) will be held on Tuesday, June 4th 2024 at 09:00 (CET)…
Navamedic ASA: Annual Report 2023 Oslo, 30 April 30 2024 - Navamedic ASA has today published its Annual Report for 2023 approved by the Board…
Navamedic Q1 2024: Successful product launch and steady operational progress Oslo, 30 April 2024 – In the first quarter 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable…
Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options Oslo, 15 March 2024: The board of directors of Navamedic ASA (the "Company"), has today, on 15 March 2024, in…
Navamedic ASA: Notification of major shareholding and mandatory notification of trade Oslo, 12 March 2024 - Ingerø Reiten Investment Company AS ("IRIC") has today sold all of its shares in the…